REVVITY, INC (RVTY) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-05..
Quick ratio
Overview →Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.28B USD | Liabilities, Current |
| Cash and equivalents | 1.02B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 709.17M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 378.50M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-05 | (m) | $1.28B | $1.02B | (m) | $709.17M | $378.50M | (m) |
| 2026-04-05 | (m) | $1.24B | $860.32M | (m) | $691.38M | $387.50M | (m) |
| 2025-12-28 | (m) | $1.33B | $919.86M | (m) | $744.67M | $379.50M | (m) |
| 2025-09-28 | (m) | $1.22B | $931.39M | (m) | $680.26M | $379.92M | (m) |
| 2025-06-29 | (m) | $671.81M | $991.85M | (m) | $661.14M | $388.47M | (m) |
| 2025-03-30 | (m) | $648.19M | $1.14B | (m) | $617.42M | $381.31M | (m) |
| 2024-12-29 | $1.80B | $653.10M | $1.16B | $0.00 | $632.40M | $367.59M | 2.75× |
| 2024-09-29 | $1.83B | $687.94M | $1.23B | $0.00 | $602.14M | $404.57M | 2.66× |
| 2024-06-30 | $2.55B | $1.39B | $1.25B | $706.07M | $597.44M | $401.43M | 1.84× |
| 2024-03-31 | $2.28B | $1.37B | $998.08M | $697.33M | $588.97M | $414.03M | 1.66× |
| 2023-12-31 | $2.24B | $1.45B | $913.16M | $689.92M | $632.81M | $428.06M | 1.54× |
| 2023-10-01 | $2.07B | $1.45B | $1.14B | $292.97M | $644.57M | $435.70M | 1.43× |
| 2023-07-02 | $2.70B | $1.37B | $1.33B | $739.05M | $626.93M | $436.82M | 1.97× |
| 2023-04-02 | $3.05B | $1.56B | $2.27B | $193.96M | $586.92M | $429.42M | 1.95× |
| 2023-01-01 | (m) | $1.54B | $454.36M | (m) | $612.78M | $405.46M | (m) |
| 2022-10-02 | (m) | $1.49B | $400.74M | (m) | $540.87M | $378.26M | (m) |
| 2022-07-03 | (m) | $1.04B | $360.86M | (m) | $932.13M | $624.30M | (m) |
| 2022-04-03 | (m) | $1.26B | $669.75M | (m) | $941.72M | $645.92M | (m) |
| 2022-01-02 | (m) | $1.21B | $618.32M | (m) | $1.02B | $624.71M | (m) |
| 2021-10-03 | (m) | $1.15B | $487.37M | (m) | $947.80M | $645.42M | (m) |
| 2021-07-04 | (m) | $1.12B | $572.81M | (m) | $992.60M | $513.43M | (m) |
| 2021-04-04 | (m) | $1.52B | $988.23M | (m) | $978.60M | $529.91M | (m) |
| 2021-01-03 | (m) | $1.65B | $402.04M | (m) | $1.16B | $514.57M | (m) |
| 2020-10-04 | (m) | $1.24B | $258.29M | (m) | $797.91M | $486.56M | (m) |
| 2020-07-05 | (m) | $1.16B | $218.54M | (m) | $708.80M | $477.71M | (m) |
| 2020-04-05 | (m) | $730.14M | $195.15M | (m) | $626.15M | $393.16M | (m) |
| 2019-12-29 | (m) | $762.83M | $191.88M | (m) | $725.18M | $356.94M | (m) |
| 2019-09-29 | (m) | $1.19B | $392.97M | (m) | $646.29M | $391.82M | (m) |
| 2019-06-30 | (m) | $706.80M | $150.02M | (m) | $654.45M | $414.33M | (m) |
| 2019-03-31 | (m) | $742.27M | $134.25M | (m) | $623.93M | $376.51M | (m) |
| 2018-12-30 | (m) | $771.63M | $163.11M | (m) | $632.67M | $338.35M | (m) |
| 2018-09-30 | (m) | $686.75M | $149.51M | (m) | $551.38M | $354.24M | (m) |
| 2018-07-01 | (m) | $712.69M | $163.39M | (m) | $564.04M | $366.96M | (m) |
| 2018-04-01 | (m) | $925.98M | $180.80M | (m) | $575.74M | $374.81M | (m) |
| 2017-12-31 | (m) | $950.90M | $202.13M | (m) | $552.30M | $351.68M | (m) |
| 2017-10-01 | (m) | $597.51M | $709.49M | (m) | $440.65M | $295.18M | (m) |
| 2017-07-02 | (m) | $589.39M | $616.31M | (m) | $440.41M | $275.08M | (m) |
| 2017-04-02 | (m) | $600.61M | $288.33M | (m) | $411.08M | $264.63M | (m) |
| 2017-01-01 | (m) | $603.36M | $359.26M | (m) | $425.59M | $246.85M | (m) |
| 2016-10-02 | (m) | $547.99M | $311.66M | (m) | $443.27M | $306.04M | (m) |
| 2016-07-03 | (m) | $561.18M | $248.08M | (m) | $435.82M | $300.26M | (m) |
| 2016-04-03 | (m) | $554.55M | $210.73M | (m) | $436.75M | $314.06M | (m) |
| 2016-01-03 | (m) | $561.49M | $237.93M | (m) | $439.01M | $288.03M | (m) |
| 2015-10-04 | (m) | $554.28M | $195.07M | (m) | $414.19M | $313.05M | (m) |
| 2015-06-28 | (m) | $574.34M | $192.17M | (m) | $425.70M | $304.75M | (m) |
| 2015-03-29 | (m) | $550.58M | $168.92M | (m) | $415.38M | $291.12M | (m) |
| 2014-12-28 | (m) | $597.31M | $174.82M | (m) | $470.56M | $285.46M | (m) |
| 2014-09-28 | (m) | $567.43M | $203.68M | (m) | $427.01M | $281.62M | (m) |
| 2014-06-29 | (m) | $578.60M | $205.26M | (m) | $443.72M | $277.99M | (m) |
| 2014-03-30 | (m) | $605.46M | $224.11M | (m) | $442.98M | $279.03M | (m) |
| 2013-12-29 | (m) | $602.80M | $173.24M | (m) | $470.03M | $261.04M | (m) |
| 2013-09-29 | (m) | $589.39M | $132.30M | (m) | $428.53M | $278.35M | (m) |
| 2013-06-30 | (m) | $563.28M | $112.47M | (m) | $434.80M | $259.47M | (m) |
| 2013-03-31 | (m) | $573.35M | $125.87M | (m) | $410.78M | $259.76M | (m) |
| 2012-12-30 | (m) | $581.10M | $171.44M | (m) | $457.01M | $247.69M | (m) |
| 2012-09-30 | (m) | $582.28M | $170.83M | (m) | $394.94M | $261.40M | (m) |
| 2012-07-01 | (m) | $587.68M | $171.40M | (m) | $389.47M | $244.44M | (m) |
| 2012-04-01 | (m) | $602.79M | $144.76M | (m) | $407.87M | $251.86M | (m) |
| 2012-01-01 | (m) | $600.07M | $142.34M | (m) | $409.89M | $240.76M | (m) |
| 2011-10-02 | (m) | $875.96M | $248.10M | (m) | $359.67M | $228.55M | (m) |
| 2011-07-03 | (m) | $559.35M | $395.21M | (m) | $382.72M | $222.24M | (m) |
| 2011-04-03 | (m) | $511.21M | $415.85M | (m) | $345.49M | $224.83M | (m) |
| 2011-01-02 | (m) | $515.20M | $420.09M | (m) | $356.76M | $207.28M | (m) |
| 2010-10-03 | (m) | $513.85M | $250.99M | (m) | $323.54M | $210.16M | (m) |
| 2010-07-04 | (m) | $513.91M | $215.66M | (m) | $365.18M | $232.48M | (m) |
| 2010-04-04 | (m) | (m) | $181.74M | (m) | (m) | (m) | (m) |
| 2010-01-03 | (m) | $497.20M | $179.71M | (m) | $365.63M | $215.07M | (m) |
| 2009-10-04 | (m) | (m) | $150.59M | (m) | (m) | (m) | (m) |
| 2009-07-05 | (m) | (m) | $151.34M | (m) | (m) | (m) | (m) |
| 2008-12-28 | (m) | (m) | $179.11M | (m) | (m) | (m) | (m) |
| 2007-12-30 | (m) | (m) | $203.35M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |